Anson Funds Management LP Caladrius Biosciences, Inc. Transaction History

Anson Funds Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$0.63 - $1.03 $106,742 - $174,514	-169,432 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$0.83 - $1.22 $140,628 - $206,707	169,432 New	169,432 $143,000
Q1 2021 May 14, 2021	SELL	$1.44 - $2.89 $347,148 - $696,706	-241,075 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$1.39 - $1.87 $335,094 - $450,810	241,075 New	241,075 $345,000

Ticker CLBS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,583,200
Market Cap $25.8M
Description
Caladrius Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue. Its product candidates include HONEDRA, a recipient of SAKIGAKE designation that is in Phase II clinical trial for the treatment of critical li...

Get notified when there are updates to the investment portfolio of Anson Funds Management LP, based on Form 13F filings with the SEC.

Stay updated on Anson Funds Management LP with notifications on news.